Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008
|
|
- Diana McKinney
- 5 years ago
- Views:
Transcription
1 Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring Janis Chan Pharmacist, UCH
2 Aminoglycosides (AG) 1. Gentamicin 2. Amikacin 3. Streptomycin 4. Neomycin ( No IV form in HA) 5. Tobramycin 6. Netilmicin 7. Kanamycin 8. Sisomicin
3 Spectrum of Activity Susceptible strains of gram ve bacteria Monotherapy for less serious infections eg. Uncomplicated UTI Combination therapy: => with β-lactam / quinolone for gram -ve bacteria eg severe Pseudomonas infection => with β-lactam gram +ve bacteria eg. Enterococcal / Staphylococcal endocarditis
4 Mode of Action
5 1. Concentration-dependent Killing Peak/MIC > 8-10 => achieves clinical response rate 90% JID 1987:155:93-99
6 2. Absorption : Poor oral bioavailability (1-2%) 3. Excretion : Mainly via kidney accumulate in renal impairment 4. Volume of distribution : ~25% of total BW ( L/kg) ~ ECF ( altered sign. in malnourished, obese, ascite or in ICU patients) 5. Distribution : Poor tissue penetration into bronchial secretions, eyes and CNS (even with inflammed meninges); except in kidney, urine, perilymph of inner ears 6. t½ : 2-3 hr (normal RFT); hr (ESRF)
7 Toxicity / Side Effects Nephrotoxicity 5-10% Tends to be reversible Ototoxicity (difficult to assess) 0.5-3% (as high as 25% in some studies) Generally irreversible Others eg. Neuromuscular blockade, nausea, headache, hypersensitivity Low rate
8 Traditional Dosing (Multiple Daily Dosing Regimen: Sanford Guide 2008) Gentamicin/Tobramycin/ Netilmicin 1.7-2mg/kg Amikacin 7.5mg/kg Streptomycin (for TB) 15mg/kg Normal RFT q8h q12h q24h Impaired RFT (ml/min) : q12-24h <10 : q48h 10-50: q24h <10 : q48h : q24-72h <10 : q72-96h
9 Why change? Q8h..Q12h..Q24h.. Potential toxicities : 1. Nephrotoxicity 2. Ototoxicity More than 100 studies, reviews.. favoured ODA 1. As least as effective as traditional dosing 2. Less toxic (Course notes from Infectious diseases courses 3; HKU 21-22/07) EXTRA benefits : $$$$$ savings ( what are they??)
10 Rationales for the ODA Regimen Concentration-Dependent Killing: Higher the peak/mic ratio results higher killing rate Peak / MIC: ODA (10) vs TDA (5) Significant post-antibiotic effect (PAE) Suppress bacteria regrowth even when level below MIC Adaptive resistance (First Exposure Effect) Make organism susceptible to subsequent dose of AG (Enterobacteriaceae and P. aeruginosa in vitro) (International J. Clin Pharmacol & Therap 1997; 35(6): )
11 Main Objectives of ODA Achieve a high aminoglycoside peak (~10 x MIC) to maximize efficacy Allow a drug-free interval of 3-5 hr to toxicity High peak (>10 x MIC) Drug free 3-5 hr
12 Eligible Patients ALL adult patients requiring aminoglycoside therapy EXCEPT: 1. Pregnany; 2. Extensive burn (>20% of body surface area) 3. Severe liver disease (e.g., ascites); 4. Severe renal disease (CrCl < 20 ml/min); 5. Neutropenia; 6. Enterococcal endocarditis; 7. Gram positive infections (when the aminoglycoside is used for synergy); 8. Aminoglycosides allergy; (International J. Clin Pharmacol & Therap 1997; 35(6): ) 9. History or signs of a hearing loss or vestibular dysfunction. NB. Not well studied in children, thus not recommended
13 How Popular USA : National Survey of Extended-Interval AG Dosing (EIAD) (CID 2000; 30: ) Aim Subjects Method Results & Findings Evaluate the adoption of EIAD 500 acute care hospitals, Random sample survey (questionnaire) 1. Response rate : 49.8% (n=249) 2. Adopted: ~ ¾ (74.7%) (4x yr 1993); 3. Equal or less toxicity (87.1%); 4. Equal efficacy (76.9%); 5. Cost savings (65.6%) 6. Monitoring : Shift to single determination of serum conc at 6-18h (61%) 7. Method to adjust renal dose : - Extend interval with the same dose (47%) - By Hartford method (32%)
14 How to dose ODA (1). Fixed Dose Approach Initial dose (Fixed dose): Gentamicin/Tobramycin Netilmicin Amikacin 3.5mg/kg 4.4mg/kg 15mg/kg Subsequent dose : same dose, interval based on CrCl CrCl (ml/min) Interval 60 and above 24 hours 40 to hours 20 to hours < 20 follow serial levels to determine time of next dose (level < 1 ug/ml) (Impact guideline 3rd edition)
15 Fixed Dose Approach - Criticism 1. Not adjusted for infection type 2. Not individualized based upon kinetic properties 3. Administered to patients with renal insufficiency
16 How to dose ODA (2). Individualized Single Daily AG Dosing using patient specific and target serum conc Optimize PD parameter Minimize unnecessary excess exposure Desired conc: : Single daily Dosing Pharmacotherapy 1999 Nov 19(11): Peak conc Sepsis Pneumonia Cystitis Pyelonephritis Osteomyelitis Trough conc Gent/ Tobra < 0.3 Amikacin < 5
17 How to dose ODA (3). Sanford Guide 2008 CrCl > <10-0 ml/min Gentamicin/ Tobramycin mg/kg 5.1 q24h 4 q24h 3.5 q24h 2.5 q24h 4 q48h 3 q48h 2 q72h Netilmicin mg/kg q24h q24h q24h q24h q48h q48h Q72h Amikacin/ Streptomycin mg/kg q24h q24h q24h q24h q48h q48h Q72h
18 Therapeutic Drug Monitoring (TDM) PURPOSE: Guide AND Monitor dosing regimen Evaluate efficacy AND potential toxicity
19 TDM for Aminoglycosides NOT indicated in patients : Receiving 24-h dosing regimen (ODA) Without concurrently administered nephrotoxic drugs ( eg. Vancomycin, amphotericin B, cyclosporin) Without exposure to contrast media Not quadriplegic or amputee Not in the ICU Younger than 60 yo Duration of planned therapy < 5-7 days (Impact guideline 3rd edition)
20 Treatment Duration.. how long? 1. BNF (51) Whenever possible treatment should not > 7 days 2. JAC: 2006 (58) Hospital Henri Mondor (France) - conduct an audit to determine appropriate use of AG, based on established guidelines. Guidelines with 5 criteria:..duration of treatment should not > 5 days except for endocarditis or severe infection due to antibiotic - resistant gram -ve bacilli or Pseudomonas.
21 Monitoring for TDA TDA Initial monitoring : obtain levels after ~4-5 t 1/2 (~3rd to 4th dose ~ reach steady-state); Peak sampling : IM : 1hr post IM IVF : 30 mins post 30-60mins infusion Trough sampling : Immediately before next dose Subsequent monitoring: weekly for prolonged therapy (RFT + drug level) Adjust dose, dosing interval or both
22 Trough Peak
23 Monitoring for ODA COMMON METHODS: 1. By measuring peak and trough as TDA Peak : Gentamicin:16-24 ug/ml; Amikacin: ug/ml Trough : < 1ug/ml for both (Data provided by UCH Lab) 2. By Hartford Nomogram 3. By Barnes-Jewish Nomogram 4..
24 Level of TDA vs ODA Gentamicin Peak : Trough: Amikacin Peak : Trough: TDA (µg/ml) 5-10 < < 10 ODA (µg/ml) < < 1 # ODA : Higher Peak, Lower Trough Data from UCH Lab
25 Hartford ODA Program? Initiated by Hartford Hospital in 1994 Aim to maximize bacterial killing by optimizing peak/mic ratio and toxicities Desired model : achieve Peak/MIC ratio 10:1, drug free period <0.5ug /ml for at least 4 hr Use Gentamicin 7mg/kg/day (fixed dose) Confirm by actual patient. Patient were sorted into 3 groups acc. to RFT Outcomes from 2184 patients: Clinically apparent ototoxicity ( n=3) Nephrotoxicity (n=27) Conclusions : clinically effective, less toxicity & the monitoring method is cost effective (ACC, Mar. 1995, p )
26 Hartford Nomogram ~ Gentamicin (ACC, Mar. 1995, p ) CrCl 20ml/min CrCl 40ml/min CrCl 60ml/min
27 Hartford Nomogram-Adjusted Concentration (ug/m l) Gentamicin nomogram (3.5mg/kg) q48h q36h q Sample time after start of infusion (h)
28 Hartford Nomogram ~ Amikacin Concentration (ug/ml) Amikacin nomogram (15mg/kg) q48h q36h q24h Sample time after start of infusion (h)
29 Use of Hartford Nomogram to Monitor Once Daily Aminoglycosides 1. Obtain random level 6-14 hrs after dose given (every dose is the 1st dose) MUST state the Time of sampling and Dosing Protocol (mg/kg) 2. Plot the obtained value on the Nomogram 3. Determine the appropriateness of dosing interval
30 Hartford Nomogram-Adjusted 7 Gentamicin nomogram (3.5mg/kg) C oncentration (ug/m l) X X X q48h q36h q24h X X X X Sample time after start of infusion (h)
31 Case study 1 A patient received 3.5mg/kg of gentamicin at A level drawn at 1530 was 3.8 mcg/ml. Using the nomogram, determine the appropriate dosing interval. Time after infusion to blood drawn : 8.5 hrs Gentamicin level : 3.8mcg/ml Suggested dosing interval : Q36h 7 Gentamicin nomogram (3.5mg/kg) Concentration (ug/ml) X q48 q36h q Sample time after start of infusion (h)
32 Case study 2 A patient received 5mg/kg of gentamicin at A level drawn at 1900 was 8mcg/ml. Using the nomogram, determine the appropriate dosing interval. Time after infusion to blood drawn : 12 hrs Gentamicin level : (8/1.4)=5.7mcg/ml Suggested dosing interval : Stop 7 Gentamicin nomogram (3.5mg/kg) Concentration (ug/ml) q48 q36h q24 X Sample time after start of infusion (h)
33 Pharmacist Role??? Any? Significant? Effective?
34 Clinical & economic outcomes of Pharm-managed aminoglycoside or vancomycin therapy AJHP Vol 62 Aug 1, 2005 Aim Subjects Method Results & Findings Evaluate the association bet. Pharm-managed AG or VC tx for hospitalized Medicare pat. who had diagnoses indicating probable tx with these abx and the major health care outcomes (death rate, length of stay, Medicare charge, hearing loss, RFT) 199,082 Medicare patients treated in 961 hospitals (in 1995) Questionnaires and data search 484/961 hospitals (>50%) offered this service Hospitals without such services shown: (p < ) Death rate 6.71% (1048 pt) Length of stay % ( d) Total Medicare charges 6.3% ($140,745,924) Drug charges 8.15% ($34,769,250) Lab. charges 7.8% ($22,530,474) Hearing loss 46.42% (134 pt) Renal impairment 33.95% (2801pt) Presence of this pharmaceutical service significantly improved health care & economic outcomes in the study group
35 Pharmacist-managed Drug Therapy Definition: A pharm under the authorization of a prescriber, ordering lab tests, initiating drug therapy or adjusting dosage to obtain the desired therapeutic outcome eg. Anticoagulant, Antibiotics Fastest growing clinical pharmacy service in US hospitals ( 25% of hospitals studied in 1989, 70% in 1998; 180%) Pharmacist-managed AG/VC therapy from >30% of hospitals in 1992 to > 60% in 1998 (~ 100%) /961 hospitals to ALL Medicare pts (730328) results in 3.67 X outcomes AJHP Vol 62 Aug 1, 2005
36 To Start With 1. PHARMACISTS (~ 15 min/patient/day) 2. Familiarize drug PK/PD eg. training packet for pharmacist, CE. 3. Find useful tools for dose calculation, eg. formulae, automated calculators 4. Communicate with physicians, nurses, hospital administrators
37
38
39
40
41
Introduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationCLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES THE AMINOGLYCOSIDES:
CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu THE AMINOGLYCOSIDES: 1944-1975 Drug
More informationEffective 9/25/2018. Contact for previous versions.
Pharmacokinetic and Pharmacodynamic Dose Optimization of Antibiotics (β-lactams, aminoglycosides, and ciprofloxacin) for the Treatment of Gram-Negative Infections Adult Inpatient/Emergency Department Clinical
More informationCLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES
CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu THE AMINOGLYCOSIDES: 1944-1975 Drug
More informationPatients. Excludes paediatrics, neonates.
Full title of guideline Author Division & Speciality Scope Gentamicin Prescribing Guideline For Adult Patients Annette Clarkson, Specialist Clinical Pharmacist Antimicrobials and Infection Control All
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationUpdate on Therapeutic Drug Monitoring - Aminoglycosides. Antimicrobial Stewardship Forum Cardiff Nov. 2nd 2015
Update on Therapeutic Drug Monitoring - Aminoglycosides Antimicrobial Stewardship Forum Cardiff Nov. 2nd 2015 Andrew Lovering Antimicrobial Reference Laboratory North Bristol NHS Trust What are common
More informationSpeciality: Therapeutics
Gentamicin Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of submission May 2017 Date on which
More informationONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS
ONCE DAILY GENTAMICIN DOSING AND MONITORING IN ADULTS POLICY QUESTIONS AND ANSWERS Contents 1. How to I calculate a gentamicin dose?... 2 2. How do I prescribe gentamicin on the cardex?... 2 3. Can I give
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationThis controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationGeneral Infectious Disease Concepts/Resources
General Infectious Disease Concepts/Resources Learning Objectives: 1. Distinguish between foundational infectious disease concepts including gram positive and negative bacteria, bacteriostatic and bactericidal
More informationMICU Antibiotics and Associated Drug Interactions
MICU Antibiotics and Associated Drug Interactions Resistant Bacteria MICU patient are at risk for resistant organisms: Recent hospitalizations From a skilled nursing facility Immunocompromised patients
More informationDETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*
44 DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY* AUTHOR: Cecilia C. Maramba-Lazarte, MD, MScID University of the Philippines College of Medicine-Philippine
More informationAntibiotic Pharmacokinetics and Pharmacodynamics for Laboratory Professionals
Antibiotic Pharmacokinetics and Pharmacodynamics for Laboratory Professionals Tom Dilworth, PharmD Aurora Health Care thomas.dilworth@aurora.org Objectives Describe the pharmacokinetics and pharmacodynamics
More informationOPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
More informationAntimicrobial Stewardship Strategy: Dose optimization
Antimicrobial Stewardship Strategy: Dose optimization Review and individualization of antimicrobial dosing based on the characteristics of the patient, drug, and infection. Description This is an overview
More informationAntimicrobial therapy in critical care
Antimicrobial therapy in critical care KARLEE JOHNSTON LEAD PHARMACIST DIVISION OF CRITICAL CARE CANBERRA HOSPITAL AND HEALTH SERVICE Outline 1. Let s talk about sepsis 2. PK/PD considerations 3. Selecting
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More informationCefazolin vs. Antistaphyloccal Penicillins: The Great Debate
Cefazolin vs. Antistaphyloccal Penicillins: The Great Debate Annie Heble, PharmD PGY2 Pediatric Pharmacy Resident Children s Hospital Colorado Microbiology Rounds March 22, 2017 Image Source: Buck cartoons
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationJerome J Schentag, Pharm D
Clinical Pharmacy and Optimization of Antibiotic Usage: How to Use what you have Learned in Pharmacokinetics and Pharmacodynamics of Antibiotics Jerome J Schentag, Pharm D Presented at UCL on Thursday
More informationCurricular Components for Infectious Diseases EPA
Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationBuilding a Better Mousetrap for Nosocomial Drug-resistant Bacteria: use of available resources to optimize the antimicrobial strategy
Building a Better Mousetrap for Nosocomial Drug-resistant Bacteria: use of available resources to optimize the antimicrobial strategy Leonardo Pagani MD Director Unit for Hospital Antimicrobial Chemotherapy
More informationDisclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAppropriate Antimicrobial Therapy for Treatment of
Appropriate Antimicrobial Therapy for Treatment of Staphylococcus aureus infections ( MRSA ) By : A. Bojdi MD Assistant Professor Inf. Dis. Dep. Imam Reza Hosp. MUMS Antibiotics Still Miracle Drugs Paul
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety
More information1 TRADE NAME OF THE MEDICINAL PRODUCT. Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 TRADE NAME OF THE MEDICINAL PRODUCT Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2ml contains 20mg of Gentamicin as Gentamicin Sulfate Excipient
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationMIACIN HIKMA PHARMACEUTICALS
09-15 MIACIN HIKMA PHARMACEUTICALS Amikacin (as sulfate) Solution for injection DESCRIPTION Amikacin sulfate is semi-synthetic aminoglycoside antibiotic derived from kanamycin. Clinical Pharmacology Intramuscular
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationChapter 51. Clinical Use of Antimicrobial Agents
Chapter 51 Clinical Use of Antimicrobial Agents History of antimicrobial therapy Early 17 th century Cinchona bark was used as an important historical remedy against malaria. 1909 Paul Ehrlich sought a
More informationDETERMINANTS OF TARGET NON- ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING β-lactams
DETERMINANTS OF TARGET NON- ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING β-lactams Jan J. De Waele MD PhD Surgical ICU Ghent University Hospital Ghent, Belgium Disclosures Financial: consultancy for
More informationInitial Management of Infections in the Era of Enhanced Antimicrobial Resistance
Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance Robert C Welliver Sr, MD Hobbs-Recknagel Endowed Chair in Pediatrics Chief, Pediatric infectious Diseases Children s Hospital
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Key Points Early and rapid diagnosis of infection and prompt initiation of appropriate antimicrobial therapy, if warranted, are fundamental to reducing the mortality
More information2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania
2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania Day 1: Saturday 30 th September 2017 09:00 09:20 Registration
More informationDRUG GUIDELINE GENTAMICIN (SULFATE)
DRUG GUIDELINE GENTAMICIN (SULFATE) SCOPE (Area): FOR USE IN: All ward areas, except as outlined below EXCLUSIONS: Paediatrics (seek Paediatrician advice) SCOPE (Staff): Medical, Nursing and Pharmacy BRAND
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE
ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationContribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections
Contribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections Francois JEHL Laboratory of Clinical Microbiology University Hospital Strasbourg
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More information2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania
2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania Day 1: Saturday 30 th September 2017 Time Topic/Activity
More informationPharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care
Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care Jennifer McCann, PharmD, BCCCP State Director of Clinical Pharmacy Services St. Vincent Health Indiana Conflicts of Interest No
More informationCHSPSC, LLC Antimicrobial Stewardship Education Series
CHSPSC, LLC Antimicrobial Stewardship Education Series March 8, 2017 Pharmacokinetics/Pharmacodynamics of Antibiotics: Refresher Part 1 Featured Speaker: Larry Danziger, Pharm.D. Professor of Pharmacy
More informationFACTORS AFFECTING THE POST-DIALYSIS LEVELS OF VANCOMYCIN AND GENTAMICIN IN HAEMODIALYSIS PATIENTS. Acute-Haemodialysis Team St.
FACTORS AFFECTING THE POST-DIALYSIS LEVELS OF VANCOMYCIN AND GENTAMICIN IN HAEMODIALYSIS PATIENTS. Acute-Haemodialysis Team St. Helier s Hospital Vancomycin and Gentamicin Audit Renal Unit St Helier Hospital
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationIntroduction to Antimicrobial Therapy
Introduction to Antimicrobial Therapy Christine Kubin Classification of Antimicrobials Antimicrobials are drugs that destroy microbes, prevent their multiplication or growth, or prevent their pathogenic
More informationTreatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:
More informationBest Antimicrobials for Staphylococcus aureus Bacteremia
Best Antimicrobials for Staphylococcus aureus Bacteremia I. Methicillin Susceptible Staph aureus (MSSA) A. In vitro - Anti-Staphylococcal β-lactams (Oxacillin, Nafcillin, Cefazolin) are more active B.
More informationAntibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee
Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also
More informationIntroduction to Antimicrobial Therapy
Introduction to Antimicrobial Therapy Christine Kubin, Pharm.D., BCPS Clinical Pharmacist, Infectious Diseases Case #2 68 y.o. female with HTN, anxiety with chest pain symptoms 7/27/05: Cath - 3 vessel
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationTDM of antibiotics. Paul M. Tulkens, MD, PhD
TDM of antibiotics (Laboratory testing guideline in the intensive care unit) Paul M. Tulkens, MD, PhD Pharmacologie cellulaire et moléculaire Louvain Drug Research Institute, Université catholique de Louvain,
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationTreatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents
Treatment of peritonitis in patients receiving Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Jude Allen (Pharmacist) Additional author(s): Dr David Lewis, Dr Dimitrios Poulikakos,
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationCF WELL Pharmacology: Microbiology & Antibiotics
CF WELL Pharmacology: Microbiology & Antibiotics Bradley E. McCrory, PharmD, BCPS Clinical Pharmacy Specialist Pulmonary Medicine Cincinnati Children s Hospital Medical Center January 26, 2017 Disclosure
More informationAminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.
Aminoglycosides The only bactericidal protein synthesis inhibitors. They bind to the ribosomal 30S subunit. Inhibit initiation of peptide synthesis and cause misreading of the genetic code. Streptomycin
More informationPharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient
Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient Rania El-Lababidi, Pharm.D., BCPS (AQ-ID), AAHIVP Manager, Pharmacy Education and Training Cleveland Clinic Abu Dhabi
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Antibiotic treatment and monitoring for suspected or confirmed early-onset neonatal infection bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to
More informationNational Antimicrobial Prescribing Survey
Indication documented Surgical prophylaxis >24 hrs Allergy mismatch Microbiology mismatch Incorrect route Incorrect dose/frequency Incorrect duration Therapeutic Guidelines Local guidelines * Non-compliant
More informationAmikacin monotherapy for pan-resistant Pseudomonas aeruginosa sepsis
AAC Accepts, published online ahead of print on 7 September 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00441-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationOriginal Research Article
Study of Preterm Infants with Different Gestational Age: Modifying Amikacin Sulphate Dosage Regimen 1 1,2 Bindiya Chauhan, Sunil S Jalalpure Dr. Prabhakar Kore Basic Science Research Center, KLE Academy
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationESCMID Online Lecture Library. by author
Treatment of community-acquired meningitis including difficult to treat organisms like penicillinresistant pneumococci and guidelines (ID perspective) Stefan Zimmerli, MD Institute for Infectious Diseases
More informationCombination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model
Journal of Antimicrobial Chemotherapy (1985) 15, Suppl. A, 313-321 Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model Joyce J.
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationAntimicrobials Update
Antimicrobials Update Rosie Amini, PharmD. BCPS Antimicrobial Stewardship Program Coordinator Swedish Medical Center Disclosures: Dr. Amini has no significant financial interest in any of the products
More information